Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, United States.
Vaccine. 2013 Feb 4;31(7):1080-5. doi: 10.1016/j.vaccine.2012.12.030. Epub 2012 Dec 23.
Large observational vaccine safety studies often use automated diagnoses extracted from medical care databases to identify pre-specified potential adverse events following immunization (AEFI). We assessed the secular trends and variability in the number of diagnoses per encounter regardless of immunization status referred as diagnostic code density, by healthcare setting, age, and pre-specified condition in eight large health care systems of the Vaccine Safety Datalink project during 2001-2009. An increasing trend in diagnostic code density was observed in all healthcare settings and age groups, with variations across the sites. Sudden increases in diagnostic code density were observed at certain sites when changes in coding policies or data inclusion criteria took place. When vaccine safety studies use an historical comparator, the increased diagnostic code density over time may generate low expected rates (based on historical data) and high observed rates (based on current data), suggesting a false positive association between a vaccine and AEFI. The ongoing monitoring of the diagnostic code density can provide guidance on study design and choice of appropriate comparison groups. It can also be used to ensure data quality and allow timely correction of errors in an active safety surveillance system.
大型观察性疫苗安全研究通常使用从医疗保健数据库中提取的自动诊断来识别预先指定的免疫接种后潜在不良事件(AEFI)。我们评估了 2001 年至 2009 年期间,疫苗安全数据链项目的八个大型医疗保健系统中,无论免疫状态如何,按医疗保健环境、年龄和预先指定条件,每次就诊的诊断代码密度(称为诊断代码密度)的季节性趋势和变异性。在所有医疗保健环境和年龄组中,都观察到诊断代码密度呈上升趋势,并且各个地点之间存在差异。当编码政策或数据纳入标准发生变化时,某些地点的诊断代码密度会突然增加。当疫苗安全性研究使用历史对照时,随着时间的推移诊断代码密度的增加可能会产生低预期率(基于历史数据)和高观察率(基于当前数据),表明疫苗和 AEFI 之间存在假阳性关联。对诊断代码密度的持续监测可以为研究设计和选择适当的对照组提供指导。它还可以用于确保数据质量,并允许在主动安全监测系统中及时纠正错误。